Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Journal article
Keddie S. et al, (2023), Brain, 146, 4562 - 4573
Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease.
Journal article
Bellanti R. et al, (2023), J Neurol Neurosurg Psychiatry
Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.
Journal article
Moodley K. et al, (2023), J Peripher Nerv Syst
Reply: Peripherin is a biomarker of axonal damage in Guillain Barré syndrome: a pathophysiological annotation.
Journal article
Keddie S. et al, (2023), Brain
AL amyloidosis presenting with isolated lumbosacral radiculoplexus neuropathy.
Journal article
Bellanti R. et al, (2023), Pract Neurol
Utilising clinical parameters to improve the selection of nerve biopsy candidates.
Journal article
Kopanidis P. et al, (2023), Intern Med J
Cerebrospinal Fluid Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.
Journal article
Al-Hakem H. et al, (2023), Neurology
Long-term tactile hypersensitivity after nerve crush injury in mice is characterized by the persistence of intact sensory axons
Journal article
Kim HW. et al, (2023), Pain
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis
Journal article
FEHMI J. et al, (2023), PLoS One
Antineurofascin IgG2-associated paediatric autoimmune nodopathy
Journal article
Harris RE. et al, (2023), Developmental Medicine and Child Neurology
Guillain-Barré syndrome following Zika virus infection is associated with a diverse spectrum of peripheral nerve reactive antibodies
Journal article
DAVIES AJ. et al, (2022), Neurology, Neuroimmunology and Neuroinflammation
TACROLIMUS-INDUCED CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPA- THY (CIDP): A CASE SERIES
Conference paper
Evans M. et al, (2022), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 93
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort.
Journal article
Leonhard SE. et al, (2022), Neurology
INTER-LABORATORY VALIDATION OF NODAL/PARANODAL ANTIBODY TESTING
Conference paper
Rinaldi S. et al, (2022), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 27, S154 - S155
MYELINATED HUMAN SENSORY NEURONS PROVIDE A PLATFORM FOR THE REPRODUCIBLE SCREENING OF PERIPHERAL NERVE-REACTIVE AUTOANTIBODIES IN PATIENT SERA
Conference paper
Fehmi J. et al, (2022), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 27, S33 - S34
PERSISTENCE OF INTACT SENSORY AFFERENTS AND MYELIN THINNING CORRELATES WITH LONG-TERM HYPERSENSITIVITY AFTER PARTIAL CRUSH OF THE PERIPHERAL NERVE
Conference paper
Kim HW. et al, (2022), JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 27, S33 - S33
Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barré syndrome mouse model.
Journal article
McGonigal R. et al, (2022), J Clin Invest
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values.
Journal article
Arends S. et al, (2022), Clin Neurophysiol, 138, 231 - 240
International validation of the Erasmus GBS Respiratory Insufficiency Score.
Journal article
Doets AY. et al, (2022), Ann Neurol
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry
Journal article
Pizzamiglio C. et al, (2022), European Journal of Neurology